These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38185955)

  • 21. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.
    Mahadeva S; Mahfudz AS; Vijayanathan A; Goh KL; Kulenthran A; Cheah PL
    J Dig Dis; 2013 Nov; 14(11):604-10. PubMed ID: 23859493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis.
    Cai C; Song X; Chen X; Zhou W; Jin Q; Chen S; Ji F
    Can J Gastroenterol Hepatol; 2021; 2021():8859338. PubMed ID: 33542909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
    Ajmera V; Loomba R
    Semin Liver Dis; 2018 Feb; 38(1):14-20. PubMed ID: 29471562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of acoustic radiation force impulse imaging elastography in the assessment of steatohepatitis and fibrosis in rat models.
    Guo Y; Lin H; Dong C; Zhang X; Wen H; Shen Y; Wang T; Chen S; Liu Y; Chen X
    Med Eng Phys; 2018 Sep; 59():30-35. PubMed ID: 30042031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.
    Rudolph B; Bjorklund N; Ovchinsky N; Kogan-Liberman D; Perez A; Liszewski M; Levin TL; Ewart M; Liu Q; Xue X; Viswanathan S; Strickler HD
    Contemp Clin Trials; 2018 Dec; 75():51-58. PubMed ID: 30401631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease.
    Karagiannakis DS; Markakis G; Lakiotaki D; Cholongitas E; Vlachogiannakos J; Papatheodoridis G
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):961-966. PubMed ID: 35913779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in ultrasound elastography for nonalcoholic fatty liver disease.
    Yoneda M; Honda Y; Nogami A; Imajo K; Nakajima A
    J Med Ultrason (2001); 2020 Oct; 47(4):521-533. PubMed ID: 32748075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.
    Sebastiani G; Milic J; Gioe C; Al Hinai AS; Cervo A; Lebouche B; Deschenes M; Cascio A; Mazzola G; Guaraldi G
    Lancet HIV; 2022 Mar; 9 Suppl 1():S4. PubMed ID: 35304846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease.
    Younossi ZM; Felix S; Jeffers T; Younossi E; Nader F; Pham H; Afendy A; Cable R; Racila A; Younoszai Z; Lam BP; Golabi P; Henry L; Stepanova M
    JAMA Netw Open; 2021 Sep; 4(9):e2123923. PubMed ID: 34529067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
    Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
    Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Hudert CA; Tzschätzsch H; Guo J; Rudolph B; Bläker H; Loddenkemper C; Luck W; Müller HP; Baumgart DC; Hamm B; Braun J; Holzhütter HG; Wiegand S; Sack I
    Radiology; 2018 Jul; 288(1):99-106. PubMed ID: 29762096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of shear wave elastography compared with transient elastography and other markers of liver fibrosis.
    Ayonrinde OT; Zelesco M; Welman CJ; Abbott S; Adris N
    Intern Med J; 2022 Apr; 52(4):640-650. PubMed ID: 34726820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver Stiffness Evaluation by Transient Elastography in Type 2 Diabetes Mellitus Patients with Ultrasound-proven Steatosis.
    Sporea I; Mare R; Lupușoru R; Sima A; Sirli R; Popescu A; Timar R
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):167-74. PubMed ID: 27308647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.
    Lupsor M; Badea R; Stefanescu H; Grigorescu M; Serban A; Radu C; Crişan D; Sparchez Z; Iancu S; Maniu A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):53-60. PubMed ID: 20361076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
    Han MA; Saouaf R; Ayoub W; Todo T; Mena E; Noureddin M
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):379-390. PubMed ID: 28277807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.
    Calleja JL; Rivera-Esteban J; Aller R; Hernández-Conde M; Abad J; Pericàs JM; Benito HG; Serra MA; Escudero A; Ampuero J; Lucena A; Sánchez Y; Arias-Loste MT; Iruzubieta P; Romero-Gómez M; Augustin S; Crespo J
    Liver Int; 2022 Aug; 42(8):1783-1792. PubMed ID: 35643936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
    Fitriakusumah Y; Lesmana CRA; Bastian WP; Jasirwan COM; Hasan I; Simadibrata M; Kurniawan J; Sulaiman AS; Gani RA
    BMC Gastroenterol; 2019 Mar; 19(1):43. PubMed ID: 30894137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
    Westfall E; Jeske R; Bader AR
    Am Fam Physician; 2020 Nov; 102(10):603-612. PubMed ID: 33179890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.